Beranda › Karsinoma Urotelial (Sel Transisional) › Georgia › Atlanta
Uji klinis Karsinoma Urotelial (Sel Transisional) di Atlanta, GA
8 studi untuk Karsinoma Urotelial (Sel Transisional) mencari peserta di lokasi sekitar Atlanta (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Menerima pesertaFase 3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Winship Cancer Institute of Emory University, Atlanta
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Menerima pesertaFase 1
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Menerima pesertaFase 1
- Emory University - Winship Cancer Institute, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- Winship Cancer Institute - Emory University, Atlanta
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
Menerima pesertaFase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Atlanta
Uji klinis Karsinoma Urotelial (Sel Transisional) di kota lain
- Nashville, TN23 studi
- New York City, NY22 studi
- Houston, TX19 studi
- Dallas, TX18 studi
- Edison, NJ18 studi
- Los Angeles, CA17 studi
- Queens, NY15 studi
- Chicago, IL14 studi
- Arlington, VA12 studi
- Boston, MA11 studi
- San Antonio, TX11 studi
- Austin, TX10 studi
Studi lain di Atlanta
- Kanker (semua jenis)49 studi
- Kanker Paru Non-Sel Kecil47 studi
- Mieloma Multipel42 studi
- Kanker Payudara41 studi
- Kanker Prostat33 studi
- Leukemia Mieloid Akut31 studi
- Kanker Ovarium29 studi
- Kanker Kolorektal29 studi
- Kanker Paru29 studi
- Kanker Metastatik28 studi
- Gangguan Depresi Mayor25 studi
- Gagal Jantung25 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.